Top compounds associated with response to ZNF606


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 2e-10
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 8e-10
mRNA BX-912 GDSC1000 pan-cancer AAC 0.18 2e-08
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-07
mRNA KIN001-102 GDSC1000 pan-cancer AAC 0.16 3e-07
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC 0.17 4e-07
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.16 4e-07
mRNA GSK690693 GDSC1000 pan-cancer AAC 0.16 1e-06
mRNA barasertib CTRPv2 pan-cancer AAC 0.16 2e-06
Download CSV